Acasunlimab

4 trials

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

4 Completed trials

1 Sponsors

15 Countries

Phase III

Phase II

Phase I (FiH)

Phase III: 1 Phase II: 2 Phase I (FiH): 1

Oversight events:

1 unexpected event across 1 trial

View oversight register →

Indications tested

Malignant melanoma 1 Non-small cell lung cancer metastatic 1 Non-small cell lung cancer 1

Sponsors using this IMP

All trials

4 total

Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer Ended

2024-512998-27-00 Phase III 15 countries Genmab A/S
Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung… Ended

2024-513770-22-00 Phase II 7 countries Genmab A/S
GEN1046 Safety Trial in Patients With Malignant Solid Tumors Ended

2023-509059-15-00 Phase I (FiH) 4 countries Genmab A/S
Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned… Ended

2025-520468-16-00 Phase II 4 countries Genmab A/S

Showing 1–4 of 4 trials

← All drugs A–Z